Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ?
NCT02852772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2017-07-28
Summary
Chronic kidney disease (CKD), frequent in PLHIV, is a risk factor for cognitive impairment. Micro-albuminuria is an early manifestation of CKD and a marker of vascular risk, notably affecting the small vessels. In the older general population microalbuminuria is associated with greater annual cognitive decline and has been proposed as an easily and inexpensive measured marker predicting future cognitive function decline. Ageing of the PLH leads to an increase of cognitive disorders and chronic renal failure incidence and could imply a common underlying mechanism affecting the renal and cerebral microvasculature. In this setting the investigators undertake this prospective, cross-sectional, case-control study to determine whether the presence of a microalbuminuria at least 5 years ago in PLHs with sustained good combination antiretroviral therapy (cART)-controlled immunovirological parameters could be a marker predicting future cognitive impairment. They chose PLHs infected for at least 5 years and with cART-sustained immunovirological control for at least 1 year.
Conditions
Interventions
- BEHAVIORAL
-
Cognitive function tests
Sponsors & Collaborators
-
Fondation Ophtalmologique Adolphe de Rothschild
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2016-11-07
- Completion
- 2016-11-07
Countries
- France
Study Locations
More Related Trials
-
Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients
NCT02082574 ·Status: COMPLETED
-
Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients
NCT03279835 ·Status: COMPLETED
-
Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
NCT00476671 ·Status: COMPLETED
-
Thinking and Memory Problems in People With HIV
NCT01875588 ·Status: RECRUITING
-
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
NCT03296202 ·Status: RECRUITING
-
Observational Study of HIV-associated Neurocognitive Disorder
NCT01966094 ·Status: COMPLETED
-
Exploring Racial Disparities in Sleep Health and Neurocognitive Function
NCT04015830 ·Status: COMPLETED ·Phase: NA
-
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients
NCT00893815 ·Status: COMPLETED
-
Revealing Increased Axonal Loss in Treated HIV Patients
NCT02003989 ·Status: COMPLETED
-
Executive Functioning Training Study
NCT05598047 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
NCT01749007 ·Status: COMPLETED
-
Prognosis of a First-Ever Stroke in Persons Living With HIV
NCT02748252 ·Status: TERMINATED
-
Renal Function Assessment in HIV Patient
NCT00821847 ·Status: COMPLETED
-
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
NCT00782808 ·Status: COMPLETED
-
HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
NCT00777426 ·Status: COMPLETED
-
Mental Ability Challenge Study in Adults With and Without HIV
NCT03244488 ·Status: COMPLETED
-
Predictors of Neuro-cognitive Decline and Survival in HIV-infected Subjects
NCT00864292 ·Status: COMPLETED
-
Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
NCT01367236 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic
NCT02187796 ·Status: COMPLETED
-
The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
NCT00540137 ·Status: COMPLETED ·Phase: PHASE4
-
Coronary Artery Disease (CAD) in Suppressed HIV-infected
NCT02898896 ·Status: TERMINATED ·Phase: NA
-
Speed of Processing Training in Adults With HIV
NCT02758093 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Albuminuria HIV-Infected Patients
NCT00524992 ·Status: COMPLETED
-
The Targeted Neurocognitive Training (TNT) Study
NCT05773430 ·Status: SUSPENDED ·Phase: NA